LAB

0.60102.07%
HK

Hanjoon Kim

Chief Financial Officer

Mr. Hanjoon Kim, also known as Alex, is Chief Financial Officer of Standard BioTools Inc. from November 11, 2024 and served as its Chief Operating Officer since joining in April 04, 2022 until November 11, 2024 and served as its Interim Chief Financial Officer from September 1, 2024 until November 2024. Prior to this, Mr. Kim served as the chief business officer of Standard BioTools, LLC, a life science tools company, since October 2021. Previously, he served in various roles at Milliken & Company (“Milliken”) from October 2015 to May 2021, including executive vice president and president of the Healthcare Division of Milliken from June 2019 to May 2021, executive vice president of the Growth Ventures Group from April 2017 to June 2019 and as executive vice president of corporate strategy and corporate development from October 2015 to June 2019. He served as Senior Vice President of Corporate Strategy at Pall Corporation from March 2014 to September 29, 2015. Mr. Kim served as a Senior Vice President of Business Development and Strategic Planning at Pall Corporation since August 24, 2012. He joined Pall from science and technology leader Danaher Corporation, where he served as Vice President of Business Development for its Water Quality Group. In his 10-year stint at Danaher, he also held a strategic development role for its corporate function and a business unit manager position within its Motion Group. He began his career as an engineer with Westinghouse Electric Company, LLC and has held positions with General Motors Corporation and Axicon Technologies, Inc. Mr. Kim holds a Master of Business Administration from Stanford Graduate School of Business, a M.S. degree in mechanical engineering from the University of Pittsburgh and a B.S. degree in mechanical engineering from Carnegie Mellon University.

公司职务